pillbase.ru

Sohonos

Active substance: palovarotene

palovarotene

Centralised EU authorisationActive

Marketing holder: Ipsen Pharma

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 5
  • SOHONOS
    CAPSULE · PALOVAROTENE 1.5 mg/1
    15054-0015
    Ipsen Biopharmaceuticals, Inc.
  • SOHONOS
    CAPSULE · PALOVAROTENE 1 mg/1
    15054-0010
    Ipsen Biopharmaceuticals, Inc.
  • SOHONOS
    CAPSULE · PALOVAROTENE 5 mg/1
    15054-0050
    Ipsen Biopharmaceuticals, Inc.
  • SOHONOS
    CAPSULE · PALOVAROTENE 10 mg/1
    15054-0100
    Ipsen Biopharmaceuticals, Inc.
  • SOHONOS
    CAPSULE · PALOVAROTENE 2.5 mg/1
    15054-0025
    Ipsen Biopharmaceuticals, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-4925-763f-831c-7e498214d1d0,01a1208e-05fa-73f2-8845-3be61e5cbfb2,01a1208f-910e-713f-b6db-589389f5ed9a,01a12095-7670-77b2-939e-ea8d5893c122,01a1209c-e9ee-7c78-b0c4-4dbf26724683;count=5 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004867
Registration status
Active
ATC code
M09AX11
Sources
  • product · EMA · EMEA/H/C/004867 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004867 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004867 · Verified 2026-10-09